CYDY
Price:
$0.27
Market Cap:
$369.83M
CytoDyn Inc. functions as a biotechnology enterprise currently in its clinical development phase. The company primarily concentrates on crafting therapies for a variety of medical conditions, leveraging leronlimab – an innovative humanized monoclonal antibody designed to interact with the CCR5 receptor. This experimental drug is being explored for its potential applications in human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), various oncological diseases, and coronavirus disease (COVID-19). In addition, leronlimab is undergoing a Phase 1b/2 clinical investigation specifically for metastatic triple-negative breast cancer. Established in 2002, and previously operating a...[Read more]
Industry
Biotechnology
IPO Date
2006-12-13
Stock Exchange
OTC
Ticker
CYDY
According to CytoDyn Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.75. This represents a change of -48.78% compared to the average of -13.18 of the last 4 quarters.
The mean historical PE Ratio of CytoDyn Inc. over the last ten years is 14.58. The current -6.75 PE Ratio has changed -4728.65% with respect to the historical average. Over the past ten years (40 quarters), CYDY's PE Ratio was at its highest in in the August 2024 quarter at 2.25. The PE Ratio was at its lowest in in the February 2025 quarter at -18.28.
Average
14.58
Median
-2.88
Minimum
-8.74
Maximum
178.37
Discovering the peaks and valleys of CytoDyn Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 369.16%
Maximum Annual PE Ratio = 178.37
Minimum Annual Increase = -6019.50%
Minimum Annual PE Ratio = -8.74
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 178.37 | -6019.50% |
| 2024 | -3.01 | 9.84% |
| 2023 | -2.74 | 246.93% |
| 2022 | -0.79 | -88.43% |
| 2021 | -6.83 | -21.77% |
| 2020 | -8.74 | 369.16% |
| 2019 | -1.86 | 7.07% |
| 2018 | -1.74 | -44.93% |
| 2017 | -3.16 | -13.79% |
| 2016 | -3.66 | 65.30% |
The current PE Ratio of CytoDyn Inc. (CYDY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
57.54
5-year avg
33.00
10-year avg
14.58
CytoDyn Inc.’s PE Ratio is less than Immutep Limited (-0.92), less than Cellectis S.A. (-4.55), less than Clinuvel Pharmaceuticals Limited (15.85), less than Northwest Biotherapeutics, Inc. (-6.23), greater than Healios K.K. (-10.67), less than Frontage Holdings Corporation (40.60), less than Clinuvel Pharmaceuticals Limited (15.85), less than Transgene S.A. (-2.89), less than Hansa Biopharma AB (publ) (-4.11), less than BioInvent International AB (publ) (-4.54),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.92 | $73.69M | |
| -4.55 | $251.93M | |
| 15.85 | $307.51M | |
| -6.23 | $312.23M | |
| -10.67 | $193.79M | |
| 40.60 | $223.05M | |
| 15.85 | $371.02M | |
| -2.89 | $122.57M | |
| -4.11 | $245.80M | |
| -4.54 | $216.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoDyn Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoDyn Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CytoDyn Inc.'s PE Ratio?
How is the PE Ratio calculated for CytoDyn Inc. (CYDY)?
What is the highest PE Ratio for CytoDyn Inc. (CYDY)?
What is the 3-year average PE Ratio for CytoDyn Inc. (CYDY)?
What is the 5-year average PE Ratio for CytoDyn Inc. (CYDY)?
How does the current PE Ratio for CytoDyn Inc. (CYDY) compare to its historical average?